AUSTIN, Texas, Feb. 05, 2019 (GLOBE NEWSWIRE) — Aeglea BioTherapeutics, Inc. (Nasdaq:AGLE), a clinical-stage biotechnology company that designs and develops […]
VANCOUVER, British Columbia, Feb. 05, 2019 (GLOBE NEWSWIRE) — Eldorado Gold Corporation (“Eldorado” or “the Company”) provides the following updates. […]
Specialty Ingredients delivered strong results in the quarter consistent with our expectations and increasing our confidence in achieving our outlook […]